X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (29) 29
humans (20) 20
male (17) 17
hematology (14) 14
female (13) 13
middle aged (13) 13
transplantation (12) 12
adult (9) 9
aged (9) 9
treatment outcome (9) 9
abridged index medicus (8) 8
immunology (8) 8
adolescent (7) 7
leukemia (7) 7
stem cell transplantation (7) 7
bone-marrow-transplantation (6) 6
hematopoietic stem cell transplantation (6) 6
stem cells (6) 6
transplantation, homologous (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
gene expression (5) 5
graft vs host disease - immunology (5) 5
patients (5) 5
remission induction (5) 5
versus-host-disease (5) 5
acute myeloid-leukemia (4) 4
alemtuzumab (4) 4
aplastic anemia (4) 4
bone marrow (4) 4
campath-1h (4) 4
drug administration schedule (4) 4
myelodysplastic syndromes (4) 4
risk factors (4) 4
stem-cell transplantation (4) 4
survival analysis (4) 4
young adult (4) 4
acute disease (3) 3
acute myelogenous leukemia (3) 3
acute myeloid leukemia (3) 3
adults (3) 3
anemia (3) 3
aspergillosis (3) 3
cancer (3) 3
cd4-positive t-lymphocytes - immunology (3) 3
depletion (3) 3
dna (3) 3
expression (3) 3
genetic aspects (3) 3
health aspects (3) 3
hematologic neoplasms - therapy (3) 3
hematopoietic stem cells (3) 3
hemopoiesis (3) 3
immunotherapy (3) 3
leukemia, myeloid, acute - mortality (3) 3
leukemia, myeloid, acute - pathology (3) 3
leukemia, myeloid, acute - therapy (3) 3
leukocyte infusions (3) 3
lymphocytes (3) 3
lymphocytes t (3) 3
mutation (3) 3
oncology (3) 3
online only (3) 3
paroxysmal-nocturnal hemoglobinuria (3) 3
physiological aspects (3) 3
prognosis (3) 3
recurrence (3) 3
research article (3) 3
risk-factors (3) 3
therapy (3) 3
unrelated donors (3) 3
allogeneic stem cell transplantation (2) 2
aml (2) 2
anemia, aplastic - drug therapy (2) 2
animals (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
antigens, neoplasm - genetics (2) 2
antigens, neoplasm - immunology (2) 2
antilymphocyte serum (2) 2
antilymphocyte serum - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antithymocyte globulin (2) 2
article (2) 2
aspergillosis - genetics (2) 2
association (2) 2
bone-marrow (2) 2
capillaries (2) 2
cd52 antigen (2) 2
cells (2) 2
chimerism (2) 2
chronic lymphocytic-leukemia (2) 2
complete remission (2) 2
cytarabine - administration & dosage (2) 2
cytokines (2) 2
dietary fats - administration & dosage (2) 2
disease susceptibility (2) 2
donor lymphocyte infusion (2) 2
energy intake (2) 2
etoposide - administration & dosage (2) 2
europe (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1916 - 1916
Abstract Introduction: Despite recent advances in treatment, multiple myeloma (MM) is still considered incurable. Several novel therapies with different... 
Journal Article
Haematologica, ISSN 0390-6078, 2019, Volume 104, Issue 6, pp. 1168 - 1175
Monosomal karyotype confers a poor prognosis in patients with acute myeloid leukemia. Here, we determined the impact of the type of remission-induction... 
Journal Article
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, ISSN 1083-8791, 11/2019
There have been sporadic reports of the development of delayed disease recurrence after bone marrow transplantation for severe aplastic anemia despite... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1304 - 1304
Abstract Background Eltrombopag (ELT), an oral thrombopoetin-receptor agonist, has recently emerged as an encouraging and promising agent in acquired aplastic... 
Journal Article
American Journal of Hematology, ISSN 0361-8609, 01/2019, Volume 94, Issue 1, pp. 93 - 102
Adult B‐lymphoblastic leukemia (B‐ALL) is a hematological malignancy characterized by genetic heterogeneity. Despite successful remission induction with... 
ALEMTUZUMAB | CAMPATH-1H | CELLS | THERAPY | DNA METHYLATION | GENE | ADULTS | PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA | HEMATOLOGY | CHILDREN
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 119 - 119
Abstract Viral infections and disease relapses are major complications between T cell depleted allogeneic stem cell transplantation (TCD alloSCT) and donor... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2164 - 2164
Abstract Introduction: We report the first analysis of a multicenter prospective single-arm phase I/II study that assesses the safety and feasibility of... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 2132 - 2132
Abstract After allogeneic stem cell transplantation (alloSCT), donor T cells targeting patient derived hematopoietic cells can induce a Graft versus Leukemia... 
Journal Article
Annals of Hematology, ISSN 0939-5555, 2018, Volume 97, Issue 10, pp. 1785 - 1795
The presence of cytogenetic clonal heterogeneity has been associated with poor prognosis in patients with acute myeloid leukemia (AML). Here, we reassessed... 
AML | Clonal evolution | Medicine & Public Health | Hematology | Cytogenetic | Oncology | Transplantation | Clonal heterogeneity | DIAGNOSIS | COMPLETE REMISSION | ACUTE MYELOGENOUS LEUKEMIA | ADULTS | ACUTE MYELOID-LEUKEMIA | PATIENTS YOUNGER | WORKING PARTY | POOR-PROGNOSIS | INTERNATIONAL EXPERT PANEL | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Medical prognosis
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4691 - 4691
Abstract Introduction Fanconi anemia (FA) is an inherited bone marrow failure syndrome (IBMFS) due to a DNA repair mechanism defect. FA generally leads to... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1228 - 1228
Abstract Opportunistic viral infections and relapse are major complications in patients after T cell depleted allogeneic stem cell transplantation (TCD... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2288 - 2288
Abstract *The 2 first authors contributed equally to the work. Background. The best post-remission treatment for younger acute myeloid leukemia (AML) patients... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 1435 - 1435
Abstract To improve treatment outcome of patients with B cell acute lymphoblastic leukemia (B-ALL), several immunotherapeutic approaches have been developed in... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3134 - 3134
Abstract Alemtuzumab, a monoclonal antibody targeting the glycophosphatidylinositol (GPI) anchored CD52 protein, is used for in vivo and/or in vitro T cell... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 313 - 313
Abstract Patients with hematological malignancies can be successfully treated with allogeneic stem cell transplantation (alloSCT). The therapeutic potential of... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.